New York, NY -- (SBWIRE) -- 12/27/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Pengrowth Energy Corp (USA) (NYSE:PGH), New Residential Investment Corp (NYSE:NRZ), Sequenom, Inc (NASDAQ:SQNM)
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) showed a volume of 1.09 million shares by the end of last trade whereas the average volume of the stock remained 3.06 million shares. The stock opened the session at $3.33 but then moved to $3.29. At that price, the stock showed a negative performance of -1.20%. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare,
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
Pengrowth Energy Corp (USA) (NYSE:PGH) opened the session at $6.24 and closed the session at $6.17 The stock showed a negative performance of -1.12% in previous trading session. Traded with volume of 1.09 million shares in the prior session and the average volume of the stock remained 1.25 million shares. Pengrowth Energy Corporation (Pengrowth) is engaged in the development, production and acquisition of, and the exploration for, oil and natural gas reserves in the provinces of Alberta, British Columbia, Saskatchewan, Ontario and Nova Scotia. The Company’s producing properties include Lindbergh, Swan Hills Area, Greater Olds/Garrington Area and Southeast Saskatchewan. In February 2012, the Company commenced the injection of steam at its Lindbergh pilot project.
Has PGH Found The Bottom And Ready To Gain Momentum? Find Out Here
New Residential Investment Corp (NYSE:NRZ) opened the session at $6.72and closed the session at $6.69. The stock showed a negative performance of -0.30% in previous trading session. Traded with volume 1.09 million shares in the prior session and the average volume of the stock remained 2.72 million shares. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate. The Company is managed by an affiliate of Fortress Investment Group LLC, a global investment management. The Company primarily target investments in excess mortgage servicing rights, residential mortgage backed securities, residential mortgage loans and other related investments.
Why Should Investors Buy NRZ After the Recent Fall? Just Go Here and Find Out
Sequenom, Inc (NASDAQ:SQNM) the stock advanced 1.33% and finished the session at $2..9. Traded with volume of 1.08 million shares in the prior session and the average volume of the stock remained 2.09 million shares. The beta of the stock remained 0.40. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research. The Company’s development and commercialization efforts in various diagnostic areas include noninvasive women’s health-related and prenatal diagnostics,
Will SQNM Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)